JP2016539349A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539349A5
JP2016539349A5 JP2016546173A JP2016546173A JP2016539349A5 JP 2016539349 A5 JP2016539349 A5 JP 2016539349A5 JP 2016546173 A JP2016546173 A JP 2016546173A JP 2016546173 A JP2016546173 A JP 2016546173A JP 2016539349 A5 JP2016539349 A5 JP 2016539349A5
Authority
JP
Japan
Prior art keywords
biomarker
kidney disease
stage
chronic kidney
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016546173A
Other languages
English (en)
Japanese (ja)
Other versions
JP6440719B2 (ja
JP2016539349A (ja
Filing date
Publication date
Priority claimed from GBGB1317621.9A external-priority patent/GB201317621D0/en
Application filed filed Critical
Publication of JP2016539349A publication Critical patent/JP2016539349A/ja
Publication of JP2016539349A5 publication Critical patent/JP2016539349A5/ja
Application granted granted Critical
Publication of JP6440719B2 publication Critical patent/JP6440719B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016546173A 2013-10-04 2014-10-06 腎疾患のバイオマーカー Active JP6440719B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1317621.9A GB201317621D0 (en) 2013-10-04 2013-10-04 Kidney disease biomarker
GB1317621.9 2013-10-04
PCT/EP2014/071354 WO2015049390A2 (en) 2013-10-04 2014-10-06 Kidney disease biomarker

Publications (3)

Publication Number Publication Date
JP2016539349A JP2016539349A (ja) 2016-12-15
JP2016539349A5 true JP2016539349A5 (enExample) 2017-09-21
JP6440719B2 JP6440719B2 (ja) 2018-12-19

Family

ID=49630222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016546173A Active JP6440719B2 (ja) 2013-10-04 2014-10-06 腎疾患のバイオマーカー

Country Status (9)

Country Link
US (1) US10545157B2 (enExample)
EP (2) EP3052939B1 (enExample)
JP (1) JP6440719B2 (enExample)
CN (1) CN105849566B (enExample)
AU (1) AU2014331070B2 (enExample)
CA (1) CA2926269C (enExample)
ES (1) ES2690486T3 (enExample)
GB (1) GB201317621D0 (enExample)
WO (1) WO2015049390A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104865384A (zh) * 2015-04-23 2015-08-26 江苏金标世纪生物科技有限公司 一种快速检测肾衰的三联试剂盒及其制备方法与应用
JP2018096710A (ja) * 2016-12-08 2018-06-21 国立大学法人金沢大学 血中タンパク質を測定することにより、ネフローゼ症候群の疾患活動性を判定する方法
WO2019032746A1 (en) 2017-08-08 2019-02-14 Fresenius Medical Care Holdings, Inc. SYSTEMS AND METHODS FOR TREATING AND ESTIMATING THE PROGRESSION OF CHRONIC RENAL DISEASE
CN108977447B (zh) * 2018-05-07 2020-06-26 中国人民解放军南京军区福州总医院 中性粒细胞明胶酶相关脂质运载蛋白核酸适配子a53及其筛选方法和应用
CN112048551A (zh) * 2020-08-25 2020-12-08 朱永俊 一种慢性肾小球疾病肾小球硬化标志物及其检测试剂盒
GB202104287D0 (en) 2021-03-26 2021-05-12 Randox Laboratories Method for determining prognosis of chronic kidney disease
CN113096815A (zh) * 2021-05-28 2021-07-09 齐齐哈尔大学 一种基于logistic回归的慢性肾病预测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062535A2 (en) * 1998-06-01 1999-12-09 University Of Maryland Biotechnology Institute Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases
US7138230B2 (en) * 2002-12-06 2006-11-21 Renovar, Inc. Systems and methods for characterizing kidney diseases
EP1802764A4 (en) 2004-09-17 2010-02-03 Univ Johns Hopkins BIOMARKER FOR BREAST CANCER
JP2007147494A (ja) * 2005-11-29 2007-06-14 Kimio Katsuta 同時物質測定方法およびそれに使用する測定用支持体
WO2009038742A2 (en) * 2007-09-20 2009-03-26 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury
US8592170B2 (en) * 2008-03-12 2013-11-26 The Trustees Of Columbia University In The City Of New York High molecular weight Ngal as a biomarker for chronic kidney disease
DK2406636T3 (en) * 2008-12-10 2019-02-18 Joslin Diabetes Center Inc PROCEDURES FOR DIAGNOSTICATION AND PREVENTION OF RENAL DISEASE
WO2011010372A1 (ja) * 2009-07-22 2011-01-27 株式会社バイオマーカーサイエンス 物質の評価方法及び評価用キット、物質のスクリーニング方法、並びに、糖尿病性腎症の発症の有無又は将来の発症リスクの判定方法及び判定用キット
US10126296B2 (en) * 2010-08-05 2018-11-13 Abbott Point Of Care Inc. Immunoassay method and device with magnetically susceptible bead capture
US10557856B2 (en) * 2010-09-24 2020-02-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Biomarkers of renal injury
EP2714937B1 (en) * 2011-06-03 2018-11-14 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds

Similar Documents

Publication Publication Date Title
JP2016539349A5 (enExample)
Vashist et al. One-step kinetics-based immunoassay for the highly sensitive detection of C-reactive protein in less than 30 min
Schley et al. Comparison of plasma and urine biomarker performance in acute kidney injury
RU2011125320A (ru) Способы, устройства и наборы для детекции или мониторинга острого повреждения почек
DK2956772T3 (en) A PROCEDURE FOR DETERMINING ACUTE LUNG FAILURE (ARDS) RELATED BIOMARKERS, A PROCEDURE FOR MONITORING DEVELOPMENT AND TREATMENT OF ARDS BY A PATIENT
Cappuzzello et al. Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure
JP2012509477A5 (enExample)
JP2009521215A5 (enExample)
Yang et al. DNA aptamer-based surface plasmon resonance sensing of human C-reactive protein
RU2011105466A (ru) Применения цитокинов семейств il-22, il-17 и il-1 при аутоиммунных заболеваниях
JP2012531593A5 (enExample)
Mahboob et al. A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages AD colorectal cancers
JP6792553B2 (ja) 腎障害および腎不全の診断および予後のための方法および組成物
ES2690486T3 (es) Biomarcador de enfermedad renal crónica
JP2014509515A5 (enExample)
Bellocchi et al. Large‐Scale characterization of systemic sclerosis serum protein profile: comparison to peripheral blood cell transcriptome and correlations with Skin/Lung fibrosis
Wang et al. A simple electrochemical immunosensor based on a gold nanoparticle monolayer electrode for neutrophil gelatinase-associated lipocalin detection
EP2718720B1 (en) Prediction of recurrence for bladder cancer by a protein signature in tissue samples
Vakili et al. Comparative analysis between urinary calprotectin and serum creatinine for early detection of intrinsic acute kidney injury
CN106796221B (zh) 川崎氏症的诊断与治疗
AU2014343709B2 (en) Biomarkers and methods for progression prediction for chronic kidney disease
Gao et al. Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure
CN201765233U (zh) 重型肝炎肝衰竭早期预警和早期诊断的酶联免疫检测板及试剂盒
JPWO2020210548A5 (enExample)
RU2017109086A (ru) Прогностический маркер hf